Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Jennifer Gass β€” scientific strength (skeptical, evidence-based)
    Based on the provided record (OpenAlex metrics + listed works), the strongest signal is high citation impact with a visible footprint in neurogenetics/neuropathology (e.g., progranulin/PGRN- and TDP-43/TARDBP-related literature) plus broader clinical-genetic variant characterization.



     Long Explanation



    Author Review: Jennifer Gass

    Evaluation style: skeptical, evidence-weighted, and careful to distinguish what is known vs. what is not provided. This review only uses information explicitly present in your input: OpenAlex-style metrics and the listed paper titles/DOIs.

    1) Visibility & impact signals (from the provided record)

    • h-index: 24
    • Total citations: 6638
    • Paper count: 60
    • OpenAlex matches shown: multiple author-IDs/namespaces exist for β€œJennifer Gass”, so author disambiguation risk is non-zero (important for fair attribution).

    2) Publication volume by year (provided counts)

    3) Citation counts by year (provided cited-by totals)

    4) Raw year-by-year data (copyable)

    Year Works count OA works count Cited-by count
    20041052
    200511167
    2006713158
    200741445
    200811462
    200922638
    201063633
    2011100
    201243319
    20131033
    201643360
    20171312326
    201822176
    2019111
    20202153
    2021312
    20222130
    2023114

    5) Scientific footprint (what the listed top works indicate)

    The highest-cited works in the provided OpenAlex excerpt cluster around frontotemporal lobar degeneration / dementia genetics and proteinopathy markers including progranulin (PGRN) and TDP-43/TARDBP biology. Example top works include:
    • PGRN genetics / FTLD-U causality:
    • FTLD-U pathology genetics:
    • TDP-43 cleavage β†’ aggregation/toxicity mechanism (cellular biology evidence):
    • TARDBP mutation discovery in inherited ALS:
    • C9orf72 poly(GA) biology:
    Note: the prompt does not provide the full methods/results text for these papers; therefore, this review refrains from claiming specific experimental details (sample sizes, assay types, statistics) beyond what can be responsibly inferred from titles alone.

    6) Topic emphasis (from provided OpenAlex topic labels)

    Provided topic scores for this β€œJennifer Gass” record emphasize Medicine, Biology, and Genetics (and related disease/gene concepts). These are classification-level signals, not direct evidence of experimental rigor.

    7) Skeptical critique (scientific strength vs. what’s missing)

    • Strength signal: The presence of highly cited, domain-relevant genetics/mechanism papers (via provided DOIs) supports that the work likely contributed to widely used molecular-genetic frameworks for specific neurodegenerative subtypes. (However, without methods/results text, we cannot grade assay quality, effect sizes, or statistical rigor.)
    • Disambiguation risk: multiple OpenAlex IDs are shown for β€œJennifer Gass”. If any of those are conflated, citation metrics (h-index/citations) and paper attribution could be biased. (This is a known bibliometric pitfall; your prompt does not provide DOI-to-identity confirmation across all works.)
    • Selection bias: only a subset of works is listed in detail. A rigorous author audit would require the full publication set, including negatives/replication attempts and methodological diversity (not only top-cited items).
    • Reproducibility opacity: titles/metadata alone do not indicate reproducibility practices (pre-registration, code availability, blinded outcome assessment, independent replication, or raw data deposition). These cannot be evaluated from the provided input.
    • Healthy-citation vs. true-impact: high citation count can reflect community adoption, but can also reflect early, influential findings later refined or partially overturned. Without full-text evidence, we cannot measure how often later work supports or corrects these findings.

    8) Evidence-weighted conclusion (confidence-scored)

    Most defensible conclusion from your input: Jennifer Gass shows high bibliometric impact and a thematic footprint in human genetics and mechanistic neurodegeneration biology (supported by the listed high-citation DOIs). Confidence: moderate for β€œthematic footprint + impact”; low for β€œexperimental rigor” because full methods/results and reproducibility artifacts are not included.
    What would change this conclusion: access to full-text methods/results for a representative set of papers (including author position, cohort sizes, experimental controls, statistical pipelines, and replication), plus confirmation that the bibliometric identity maps to a single individual across all works.


    Feedback:    

    Updated: April 09, 2026

     Analysis Wizard



    It parses the provided OpenAlex year-by-year counts and DOIs, then outputs tables and Plotly-ready arrays to visualize publication volume and cited-by trends for β€œJennifer Gass”.



     Hypothesis Graveyard



    A single universal toxicity mechanism across all FTLD/ALS genetic subtypes is unlikely; pathway heterogeneity is expected, and convergence may be partial and context-dependent rather than absolute.


    That aggregation alone causally explains toxicity without considering upstream processing/transport disruptions is probably an over-simplification; titles suggest multiple interacting mechanisms rather than aggregation as the sole driver.

     Science Art


    Author Review: Jennifer Gass Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT